IMUGENE LIMITED — Director's Dealing 2024

Jan 18, 2024

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Jens Eckstein
Date of last notice	04 October 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder)	N/A
Date of change	12 January 2024
No. of securities held prior to change	(1) 600,000 - Employee Share Option Plan - Options (2) 20,738,095 - ORDINARY FULLY PAID SHARES (3) 238,095 - OPTIONS @ $0.118 EXP 31/08/2026
Class	(4) Restricted Stock Units (RSUs)
Number acquired	(4) 1,000,000 - Restricted Stock Units (RSUs)
Number disposed	NIL
Value/Consideration	(4) - Restricted Stock Units (RSUs) issued for NIL consideration
No. of securities held after change	(1) 600,000 - Employee Share Option Plan - Options (2) 20,738,095 - ORDINARY FULLY PAID SHARES (3) 238,095 - OPTIONS @ $0.118 EXP 31/08/2026 (4) 1,000,000 - Restricted Stock Units (RSUs)
Nature of change	Issue of Restricted Stock Units under the Amended ESOP as approved by shareholders at the AGM held on 30 November 2023

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Lesley Russell
Date of last notice	04 October 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder)	N/A
Date of change	12 January 2024
No. of securities held prior to change	(1) 600,000 - Employee Share Option Plan - Options (2) 20,238,095 - ORDINARY FULLY PAID SHARES (3) 238,095 - OPTIONS @ $0.118 EXP 31/08/2026
Class	(4) Restricted Stock Units (RSUs)
Number acquired	(4) 1,000,000 Restricted Stock Units (RSUs)
Number disposed	NIL
Value/Consideration	(4) - Restricted Stock Units (RSUs) issued for NIL consideration
No. of securities held after change	(1) 600,000 - Employee Share Option Plan - Options (2) 20,238,095 - ORDINARY FULLY PAID SHARES (3) 238,095 - OPTIONS @ $0.118 EXP 31/08/2026 (4) 1,000,000 - Restricted Stock Units (RSUs)
Nature of change	Issue of Restricted Stock Units under the Amended ESOP as approved by shareholders at the AGM held on 30 November 2023.

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Jakob Dupont
Date of last notice	04 October 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder)	N/A
Date of change	12 January 2024
No. of securities held prior to change	(1) 89,286 - ORDINARY FULLY PAID SHARES (2) 89,286 - OPTIONS @ $0.118 EXP 31/08/2026 (3) 2,100,000 - Employee Share Option Plan - Options
Class	(4) Restricted Stock Units (RSUs)
Number acquired	(4) 1,000,000 - Restricted Stock Units (RSUs)
Number disposed	NIL
Value/Consideration	(4) - Restricted Stock Units (RSUs) issued for NIL consideration
No. of securities held after change	(1) 89,286 - ORDINARY FULLY PAID SHARES (2) 89,286 - OPTIONS @ $0.118 EXP 31/08/2026 (3) 2,100,000 - Employee Share Option Plan - Options (4) 1,000,000 - Restricted Stock Units (RSUs)
Nature of change	Issue of Restricted Stock Units under the Amended ESOP as approved by shareholders at the AGM held on 30 November 2023.

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be + See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Kim Drapkin
Date of last notice	04 October 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder)	N/A
Date of change	12 January 2024
No. of securities held prior to change	(1) 119,048 - ORDINARY FULLY PAID SHARES (2) 119,048 - OPTIONS @ $0.118 EXP 31/08/2026
Class	(3) Restricted Stock Units (RSUs)
Number acquired	(3) 1,000,000 - Restricted Stock Units (RSUs)
Number disposed	NIL
Value/Consideration	(3) - Restricted Stock Units (RSUs) issued for NIL consideration
No. of securities held after change	(1) 119,048 - ORDINARY FULLY PAID SHARES (2) 119,048 - OPTIONS @ $0.118 EXP 31/08/2026 (3) 1,000,000 - Restricted Stock Units (RSUs)
Nature of change	Issue of Restricted Stock Units under the Amended ESOP as approved by shareholders at the AGM held on 30 November 2023.

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

	Appendix 3Y Change of Director's Interest Notice
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Leslie Chong
Date of last notice	11 October 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder)	N/A
Date of change	12 January 2024
No. of securities held prior to change	(1) 20,300,000 - EMPLOYEE SHARE OPTION PLAN (2) 79,916,666 - ORDINARY FULLY PAID SHARES (3) 2,916,666 - LISTED OPTIONS @ $0.118, expiring 31 August 2026
Class	(4) PERFORMANCE RIGHTS AWARD
Number acquired	(4) 23,175,000
Number disposed	NIL
Value/Consideration	(4) NIL - Performance Rights issued for NIL consideration
No. of securities held after change	(1) 20,300,000 - EMPLOYEE SHARE OPTION PLAN (2) 79,916,666 - ORDINARY FULLY PAID SHARES (3) 2,916,666 - LISTED OPTIONS @ $0.118, expiring 31 August 2026 (4) 23,175,000 - PERFORMANCE RIGHTS AWARD
Nature of change	Performance Rights issued under the Amended ESOP as approved by shareholders at the AGM held on 30 November 2023.

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Imugene Limited
ABN	99 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Paul Hopper
Date of last notice	12 October 2023

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder)	Director related Parties
Date of change	12 January 2024
No. of securities held prior to change	(1) Direct Shares - 2,894,314 ORDINARY FULLY PAID SHARES (2) Indirect Shares - 317,154,000 ORDINARY FULLY PAID SHARES (3) 2,900,000 - ESOP OPTIONS (4) 2,916,666 - LISTED OPTIONS @ $0.118, expiring 31 August 2026
Class	(5) PERFORMANCE RIGHTS AWARD
Number acquired	(5) 3,901,500 - PERFORMANCE RIGHTS AWARD
Number disposed	NIL
Value/Consideration	(5) NIL- Performance Rights issued for NIL consideration
No. of securities held after change	(1) Direct Shares - 2,894,314 ORDINARY FULLY PAID SHARES (2) Indirect Shares - 317,154,000 ORDINARY FULLY PAID SHARES (3) 2,900,000 - ESOP OPTIONS (4) 2,916,666 - LISTED OPTIONS @ $0.118, expiring 31 August 2026 (5) 3,901,500 - PERFORMANCE RIGHTS AWARD

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

Nature of change

Performance Rights issued under the Amended ESOP as approved by shareholders at the AGM held on 30 November 2023.

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2